Rory Collins

136.2k total citations · 29 hit papers
245 papers, 62.1k citations indexed

About

Rory Collins is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Rory Collins has authored 245 papers receiving a total of 62.1k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Cardiology and Cardiovascular Medicine, 86 papers in Surgery and 43 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Rory Collins's work include Lipoproteins and Cardiovascular Health (65 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (37 papers) and Blood Pressure and Hypertension Studies (36 papers). Rory Collins is often cited by papers focused on Lipoproteins and Cardiovascular Health (65 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (37 papers) and Blood Pressure and Hypertension Studies (36 papers). Rory Collins collaborates with scholars based in United Kingdom, United States and China. Rory Collins's co-authors include Richard Peto, Nawab Qizilbash, Sarah Lewington, Robert Clarke, Richárd Pető, John Danesh, Peter Sleight, Salim Yusuf, Stephen MacMahon and Jon Godwin and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Rory Collins

237 papers receiving 59.6k citations

Hit Papers

Age-specific relevance of usual blood pressure to ... 1985 2026 1998 2012 2002 2015 2005 1990 2003 2.0k 4.0k 6.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
    2002 7.2k citations Sarah Lewington, Richárd Pető et al. The Lancet profile →
  2. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
    2015 6.9k citations Cathie Sudlow, Naomi E. Allen et al. profile →
  3. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
    2005 3.8k citations Rory Collins, Richard Peto et al. The Lancet profile →
  4. Blood pressure, stroke, and coronary heart disease
    1990 3.4k citations Rory Collins, Richard Peto et al. The Lancet profile →
  5. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
    2003 2.7k citations Rory Collins et al. The Lancet profile →
  6. Beta blockade during and after myocardial infarction: An overview of the randomized trials
    1985 2.4k citations Salim Yusuf, Richard Peto et al. profile →
  7. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
    1988 2.1k citations Rory Collins, Colin Baigent et al. PubMed profile →
  8. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
    2005 1.9k citations Rory Collins et al. The Lancet profile →
  9. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
    2009 1.9k citations Stephen Kaptoge, Emanuele Di Angelantonio et al. The Lancet profile →
  10. Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease
    1998 1.7k citations Rory Collins et al. profile →
  11. Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial
    2005 1.3k citations Richard Peto, Rory Collins et al. The Lancet profile →
  12. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
    2015 1.0k citations Jonathan Emberson, Rory Collins et al. The Lancet profile →
  13. Chronic infections and coronary heart disease: is there a link?
    1997 937 citations John Danesh, Rory Collins et al. The Lancet profile →
  14. SARS-CoV-2 is associated with changes in brain structure in UK Biobank
    2022 912 citations Rory Collins, Naomi E. Allen et al. profile →
  15. Lipoprotein(a) and Coronary Heart Disease
    2000 727 citations John Danesh, Rory Collins et al. Circulation profile →
  16. What makes UK Biobank special?
    2012 720 citations Rory Collins The Lancet profile →
  17. Underestimation of Risk Associations Due to Regression Dilution in Long-term Follow-up of Prospective Studies
    1999 672 citations Sarah Lewington, Linda Youngman et al. profile →
  18. Association of Apolipoprotein E Genotypes With Lipid Levels and Coronary Risk
    2007 610 citations Emanuele Di Angelantonio, Rory Collins et al. profile →
  19. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up
    2011 607 citations Zhengming Chen, Rory Collins et al. International Journal of Epidemiology profile →
  20. Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial
    2005 555 citations Richard Peto, Rory Collins et al. The Lancet profile →
  21. Unravelling the fetal origins hypothesis: is there really an inverse association between birthweight and subsequent blood pressure?
    2002 496 citations Rory Collins et al. The Lancet profile →
  22. Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks
    2018 442 citations Jackie Bosch, Rory Collins et al. profile →
  23. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England
    2020 430 citations Martin Landray, Jonathan Emberson et al. The Lancet profile →
  24. Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China
    2017 366 citations Fiona Bragg, Michael V. Holmes et al. profile →
  25. A brief history of human disease genetics
    2020 349 citations Rory Collins, Matthew E. Hurles et al. profile →
  26. Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke
    2018 329 citations Michael V. Holmes, Iona Y. Millwood et al. Journal of the American College of Cardiology profile →
  27. The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China
    2016 290 citations Sarah Lewington, Ben Lacey et al. profile →
  28. The Magic of Randomization versus the Myth of Real-World Evidence
    2020 260 citations Rory Collins, Louise Bowman et al. New England Journal of Medicine profile →
  29. Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults
    2019 209 citations Robert Clarke, Derrick Bennett et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rory Collins United Kingdom 86 23.5k 15.0k 9.8k 7.1k 7.0k 245 62.1k
Aaron R. Folsom United States 139 26.9k 1.1× 11.1k 0.7× 10.3k 1.0× 9.6k 1.3× 10.7k 1.5× 867 75.6k
Julie E. Buring United States 128 15.8k 0.7× 10.9k 0.7× 12.5k 1.3× 10.8k 1.5× 12.6k 1.8× 602 66.5k
Nancy R. Cook United States 107 14.3k 0.6× 8.8k 0.6× 6.8k 0.7× 8.3k 1.2× 9.0k 1.3× 440 51.2k
Sidney C. Smith United States 90 27.3k 1.2× 19.6k 1.3× 14.3k 1.5× 9.5k 1.3× 7.2k 1.0× 317 67.7k
Donald M. Lloyd‐Jones United States 105 34.7k 1.5× 18.0k 1.2× 11.7k 1.2× 7.1k 1.0× 9.2k 1.3× 739 69.0k
Robert J. Glynn United States 115 13.2k 0.6× 14.5k 1.0× 7.7k 0.8× 9.0k 1.3× 5.4k 0.8× 577 61.1k
Christie M. Ballantyne United States 126 19.9k 0.8× 29.4k 2.0× 16.9k 1.7× 9.0k 1.3× 3.2k 0.5× 1.1k 66.6k
Sidney C. Smith United States 51 25.6k 1.1× 14.7k 1.0× 15.1k 1.5× 9.1k 1.3× 8.5k 1.2× 82 59.9k
Neil J. Stone United States 49 15.3k 0.7× 18.9k 1.3× 14.3k 1.5× 5.6k 0.8× 5.5k 0.8× 191 45.2k
Henrik Toft Sørensen Denmark 119 13.4k 0.6× 16.9k 1.1× 5.1k 0.5× 14.3k 2.0× 9.4k 1.3× 1.6k 77.7k

Countries citing papers authored by Rory Collins

Since Specialization
Citations

This map shows the geographic impact of Rory Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rory Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rory Collins more than expected).

Fields of papers citing papers by Rory Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rory Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rory Collins. The network helps show where Rory Collins may publish in the future.

Co-authorship network of co-authors of Rory Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Rory Collins. A scholar is included among the top collaborators of Rory Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rory Collins. Rory Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berúmen, Jaime, Jason Torres, Jesús Alegre-Díaz, et al.. (2025). Polygenic prediction of coronary heart disease among 130 000 Mexican adults. European Journal of Preventive Cardiology. 33(3). 415–423.
2.
3.
Strawbridge, Rona J., Zosia Miedzybrodzka, Riccardo E. Marioni, et al.. (2024). Methods applied to neonatal dried blood spot samples for secondary research purposes: a scoping review. Critical Reviews in Clinical Laboratory Sciences. 61(8). 685–708.
4.
Feng, Qi, Ben Lacey, Jelena Bešević, et al.. (2023). UK biobank: Enhanced assessment of the epidemiology and long-term impact of coronavirus disease-2019. SHILAP Revista de lepidopterología. 1. e30–e30. 1 indexed citations
5.
Clarke, Robert, Neil Wright, Robin Walters, et al.. (2023). Genetically Predicted Differences in Systolic Blood Pressure and Risk of Cardiovascular and Noncardiovascular Diseases: A Mendelian Randomization Study in Chinese Adults. Hypertension. 80(3). 566–576. 11 indexed citations
6.
Alegre-Díaz, Jesús, Fiona Bragg, Eirini Trichia, et al.. (2023). Educational and social inequalities and cause-specific mortality in Mexico City: a prospective study. The Lancet Public Health. 8(9). e670–e679. 10 indexed citations
7.
Wijesurendra, Rohan S., Rebecca J. Sardell, Raja Jayaram, et al.. (2023). Mechanisms of rosuvastatin-related acute kidney injury following cardiac surgery: the STICS trial. European Heart Journal. 45(8). 629–631. 4 indexed citations
8.
Collins, Rory, Louise Bowman, Martin Landray, & Richard Peto. (2020). The Magic of Randomization versus the Myth of Real-World Evidence. New England Journal of Medicine. 382(7). 674–678. 260 indexed citations breakdown →
9.
Hopewell, Jemma C., Alison Offer, Richard Haynes, et al.. (2020). Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom. European Heart Journal. 41(35). 3336–3342. 26 indexed citations
10.
Holmes, Michael V., Iona Y. Millwood, Christiana Kartsonaki, et al.. (2018). Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke. Journal of the American College of Cardiology. 71(6). 620–632. 329 indexed citations breakdown →
11.
Lewington, Sarah, et al.. (2014). Outdoor temperature, blood pressure and cardiovascular disease mortality among people with diagnosed cardiovascular diseases: findings from the China Kadoorie Biobank. European Heart Journal. 35. 556–556. 1 indexed citations
12.
Mezuk, Briana, Yiping Chen, Canqing Yu, et al.. (2013). Depression, anxiety, and prevalent diabetes in the Chinese population: Findings from the China Kadoorie Biobank of 0.5million people. Journal of Psychosomatic Research. 75(6). 511–517. 38 indexed citations
13.
Reith, Christina, Martin Landray, P.J. Devereaux, et al.. (2013). Randomized Clinical Trials — Removing Unnecessary Obstacles. New England Journal of Medicine. 369(11). 1061–1065. 86 indexed citations
14.
Hopewell, Jemma C., et al.. (2012). Abstract 11959: The Impact of Genetic Variants Related to LDL-cholesterol on Risk of Ischemic Stroke and Coronary Heart Disease. Circulation.
15.
Chen, Zhengming, Rory Collins, Yongxian Guo, et al.. (2011). China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. International Journal of Epidemiology. 40(6). 1652–1666. 607 indexed citations breakdown →
16.
Kaptoge, Stephen, Emanuele Di Angelantonio, Gordon Lowe, et al.. (2009). C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. The Lancet. 375(9709). 132–140. 1871 indexed citations breakdown →
17.
Baigent, Colin, Martin Landray, Craig Leaper, et al.. (2005). First United Kingdom Heart and Renal Protection (UK-HARP-I) study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease. American Journal of Kidney Diseases. 45(3). 473–484. 146 indexed citations
18.
Danesh, John, John Koreth, Linda Youngman, et al.. (1999). Is Helicobacter pylori a Factor in Coronary Atherosclerosis?. Journal of Clinical Microbiology. 37(5). 1651–1651. 20 indexed citations
19.
Lewington, Sarah, Robert Clarke, M Shipley, Rory Collins, & R Peto. (1998). Underestimation of BP risk association due to regression dilution in long-term follow-up of prospective studies. Journal of Hypertension. 16. 3 indexed citations
20.
Collins, Rory, Salim Yusuf, & Richárd Pető. (1985). Overview of randomised trials of diuretics in pregnancy.. PubMed. 290(6461). 17–23. 212 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aaron R. Folsom Breakdown of academic impact, for papers by Julie E. Buring Breakdown of academic impact, for papers by Nancy R. Cook Breakdown of academic impact, for papers by Sidney C. Smith Breakdown of academic impact, for papers by Donald M. Lloyd‐Jones Breakdown of academic impact, for papers by Robert J. Glynn Breakdown of academic impact, for papers by Christie M. Ballantyne Breakdown of academic impact, for papers by Sidney C. Smith Breakdown of academic impact, for papers by Neil J. Stone Breakdown of academic impact, for papers by Henrik Toft Sørensen
Rankless by CCL
2026